Control of vascular tone by endogenous endothelin-1 in human pial arteries

Stroke

Volumn 29, Issue 1, 1998, Pages 175-180

  Thorin, Eric ^a   Nguyen, Thanh Dung ^a   Bouthillier, Alain ^b  

^a MONTREAL HEART INSTITUTE   (Canada)

^b NONE

Author keywords

Endothelins; Endothelium; Nitric oxide synthase; Pial arteries

Indexed keywords

ACETYLCHOLINE; ALPHA 2 ADRENERGIC RECEPTOR; ANGIOTENSIN; ENDOTHELIN 1; ENDOTHELIN RECEPTOR ANTAGONIST; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; GLIBENCLAMIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; OXYMETAZOLINE; PINACIDIL; SEROTONIN; SUBSTANCE P; TETRYLAMMONIUM;

ADOLESCENT; ADULT; ALPHA ADRENERGIC STIMULATION; ARTERY ENDOTHELIUM; ARTICLE; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN TISSUE; MALE; PIA ARTERY; POTASSIUM CONDUCTANCE; PRIORITY JOURNAL; RECEPTOR BLOCKING; REGULATORY MECHANISM; VASOCONSTRICTION;

EID: 0031963858     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.29.1.175     Document Type: Article

References (58)

1. Yanagizawa M, Kirihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411-415.
2. Yanagizawa M, Inoue A, Ishikawa T, Kasuya Y, Kimura S, Kumagaye S, Nakajima K, Watanabe TX, Sakakibara S, Goto K, Masaki T. Primary structure, synthesis, and biological activity of rat endothelin, and endothelium-derived vasoconstrictor peptide. Proc Natl Acad Sci U S A. 1988;85: 6964-6967.
3. Oliver FJ, de la Rubia G, Feener EP, Lee ME, Locken MR, Shiba T, Quertermous T, King GL. Stimulation of endothelin-1 gene expression by insulin in endothelial cells. J Biol Chem. 1991;266:23251-23256.
4. Boulanger CM, Tanner FC, Béa ML, Hahn AWA, Werner A, Lüscher TF. Oxidized low density liporpoteins induce mRNA expression and release of endothelin from human and porcine endothelium. Circ Res. 1992;70: 1191-1197.
5. Yoshizumi M, Kurihara H, Sugiyama T, Takaku F, Yanagisawa M, Masaki T, Yazaki Y. Hemodynamic shear stress stimulates enothelin-1 production by cultured endothelial cells. Biochem Biophys Res Commun. 1989;161: 859-864.
6. Tasaka K, Kitazumi K. The control of endothelin-1 secretion. Gen Pharmacol. 1994;25:1059-1069.
7. 2-adrenoceptor contribute to cerebral vasodilation. Hypertension. 1997;30:830-836.
8. Chen L, McNeill JR, Wilson TW, Gopalakrishnan V. Heterogeneity in vascular smooth muscle responsiveness to angiotensin II: role of endothelin. Hypertension. 1995;26:83-88.
9. Dohi Y, Hahn AWA, Boulanger CM, Bülher FR, Lüscher TF. Endothelin stimulated by angiotensin II augments contractility of spontaneously hypertensive rat resistance arteries. Hypertension. 1992;19:131-137.
10. Harrison VJ, Barnes K, Turner AJ, Wood E, Corder R, Vane JR. Identification of endothelin 1 and big-endothelin 1 in secretory vesicles isolated from bovine aortic endothelial cells. Proc Natl Acad Sci U S A. 1995;92: 6344-6348.
11. Ikegawa R, Matsumura Y, Tsukahara Y, Takaoka M, Morimoto S. Phosphoramidon, a metalloproteinase inhibitor, suppresses the secretion of endothelin-1 from cultured endothelial cells by inhibiting a big endothelin-1 converting enzyme. Biochem Biophys Res Commun. 1990;171: 669-675.
12. Petersson J, Hanson GC, Lindberg BF, Högestätt ED. Contractile effect of big endothelin-1 and its conversion to endothelin-1 in rabbit cerebral arteries. Naunyn Schmiedebergs Arch Pharmacol. 1996;354:656-661.
13. Gokina NI, Wellman TD, Bevan RD, Walters CL, Penar PL, Bevan JA. Role of calcium-activated potassium channels in the regulation of membrane potential and tone of smooth muscle in human pial arteries. Circ Res. 1996;79:881-886.
14. Bayliss WM. On the local reactions of the arterial wall to changes of internal pressure. J Physiol Lond. 1902;28:200-231.
15. Folkow B. Description of the myogenic hypothesis. Circ Res. 1964; 15(suppl II):II-279-II-287.
16. Alkayed NJ, Birks EK, Hudetz AG, Roman RJ, Henderson L, Harder DR. Inhibition of brain P-450 arachidonic acid epoxygenase decreases baseline cerebral blood flow. Am J Physiol 1996;271:H1541-H1546.
17. Ellis EF, Police RJ, Yancey L, McKinney JS, Amruthesh SC. Dilation of cerebral arterioles by cytochrome P-450 metabolites of arachidonic acid. Am J Physiol. 1996;259:H1171-H1177.
18. Manabe K, Shirahase H, Usui H, Kurahashi K, Fujiwara M. Endothelium-dependent contractions induced by angiotensin I and angiotensin II in canine cerebral artery. J Pharmacol Exp Ther. 1989;251:317-320.
19. Petersson J, Zygmunt PM, Brandt L, Högesstätt ED. Substance P-induced relaxation and hyperpolarization in human cerebral arteries. Br J Pharmacol. 1995;115:889-894.
20. Faraci FM. Regulation of the cerebral circulation by endothelium. Pharmacol Ther. 1994;56:1-22.
21. Hirose H, Ide K, Sasaki T, Takahashi R, Kobayashi M, Ikemoto F, Yano M, Nishikibe M. The role of endothelin and nitric oxide in modulation of normal and spastic cerebral vascular tone in the dog. Eur J Pharmacol. 1995;277:77-87.
22. Levin ER. Mechanisms of disease: endothelins. N Engl J Med. 1995;333: 356-363.
23. Masaoka H, Suzuki R, Hirata Y, Emori T, Marumo F, Hirakawa K. Raised plasma endothelin in aneurysmal subarachnoid haemorrhage. Lancet. 1989;2:1402.
24. Lerman A, Edwards BS, Hallett JW, Heublein DM, Sandberg SM, Burnett JC. Circulating and tissue endothelin immunoreactivity in advance atherosclerosis. N Engl J Med. 1990;325:997-1001.
25. Lerman A, Jr Hildebrand FL, Aarhus LL, Burnett JC. Endothelin has biologic actions at pathophysiologic concentration. Circulation. 1991;83: 1808-1814.
26. Clozel M, Breu V, Burri K, Cassal JM, Fischli W, Gray GA, Hirth G, Löffler BM, Müller M, Neidhart W, Ramuz H. Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist. Nature. 1993;365:759-761.
27. Zuccarello M, Soattin GB, Lewis AI, Breu V, Hallak H, Rapoport RM. Prevention of subarachnoid hemorrhage-induced cerebral vasospasm by oral administration of endothelin receptor antagonist. J Neurosurg. 1996;84: 503-507.
28. Kowala MC, Rose PM, Stein PD, Goller N, Recce R, Beyer S, Valentine M, Barton D, Durham SK. Selective blockade of the endothelin subtype A receptor decreases early atherosclerosis in hamsters fed cholesterol. Am J Pathol. 1995;146:819-826.
29. Toda N, Okamura T, Shimizu I, Tatsuno Y. Postmortem functional changes in coronary and cerebral arteries from humans and monkeys. Cardiovasc Res. 1985;19:707-713.
30. Garland CJ, Plane F, Kemp BK, Cocks TM. Endothelium-dependent hyperpolarization: a role in the control of vascular tone. Trends Pharmacol Sci. 1995;16:23-30.
31. G nitroarginine/indomethacin-resistant relaxation in bovine and porcine coronary arteries. Br J Pharmacol. 1996;119:1177-1186.
32. Murphy ME, Brayden JE. Nitric oxide hyperpolarizes rabbit mesenteric arteries via ATP-sensitive potassium channels. J Physiol. 1995;486:47-58.
33. Aldosoro M, Martinez C, Vila JM, Medina P, Lluch S. Influence of endothelial nitric oxide on adrenergic contractile responses of human cerebral arteries. J Cereb Blood Flow Metab. 1996;16:623-628.
34. Dunn W, Wellman G, Bevan JA. Enhanced resistance artery sensitivity to agonists under isobaric compared to isometric conditions. Am J Physiol. 1994;266:H147-H155.
35. Boulanger CM, Lüscher TF. Release of endothelin by porcine aorta: inhibition by endothelium-derived nitric oxide. J Clin Invest. 1990;85: 587-590.
36. de Nucci G, Thomas R, D'Orléans-Juste P, Antunes E, Walder C, Warner TD, Vane JR. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci U S A. 1988;85: 9797-9800.
37. Flowers MA, Wang Y, Stewart RJ, Patel B, Marsden PA. Reciprocal regulation of endothelin-1 and endothelial constitutive NOS in proliferating endothelial cells. Am J Physiol. 1995;269:H1988-H1997.
38. Warner TD, Schmidt HHHW, Murad F. Interactions of endothelins and EDRF in bovine native endothelial cells: selective effects of endothelin 3. Am J Physiol. 1992;262:H1600-H1605.
39. 2 in endothelium in maintaining resting tone and producing contractile response to acetylcholine and arachidonic acid in canine cerebral arteries. Blood Vessels. 1987;24:117-119.
40. Shirahase H, Usui H, Kurahashi K, Fujiwara M, Fukui K. Endothelium-dependent contraction induced by nicotine in isolated canine basilar artery. Life Sci. 1988;42:437-445.
41. Toda N. Mechanisms of contracting action of oxyhemoglobin in isolated monkey and dog cerebral arteries. Am J Physiol. 1990;258:H57-H63.
42. Thorin E, Atkinson J. Modulation by the endothelium of sympathetic vasoconstriction in an in vitro preparation of the rat tail artery. Br J Pharmacol. 1994;111:351-357.
43. Yang Z, Richard V, von Segesser L, Bauer E, Stulz P, Turina M, Lüscher T. Threshold concentrations of endothelin-1 potentiate contractions to norepinephrine and serotonin in human arteries. Circulation. 1990;82: 188-195.
44. Fukao M, Hattori Y, Kanno M, Sakuma I, Kitabatake A. Evidence against a role of cytochrome P450-derived arachidonic acid metabolites in endothelium-dependent hyperpolarization by acetylcholine in rat isolated mesenteric artery. Br J Pharmacol. 1997;120:439-446.
45. Bockman CS, Jeffries WB, Abel PW. Binding and functional characterization of alpha-2 adrenergic receptor subtypes on pig vascular endothelium. J Pharmacol Exp Ther. 1993;267:1126-1133.
46. Ohgushi M, Yasue H, Kugiyama K, Murohara T, Sakaino N. Contraction and endothelium dependent relaxation via alpha adrenoceptors are variable in various pig arteries. Cardiovasc Res. 1993;27:779-784.
47. 2-adrenoceptor-mediated dilations in rat cerebral arteries. Am J Physiol. 1995;269:H1171-H1174.
48. Cohen RA, Vanhoutte PM. Endothelium-dependent hyperpolarization: beyond nitric oxide and cyclic GMP. Circulation. 1995;92:3337-3349.
49. Sobey CG, Faraci FM. Effect ot nitric oxide and potassium channel agonists and inhibitors on basilar artery diameter. Am J Physiol. 1997;272:H256-H262.
50. Brayden JE, Nelson MT. Regulation of arterial tone by activation of calcium-dependent potassium channels. Science. 1992;256:532-535.
51. Chen G, Yamamoto Y, Miwa K, Suzuki H. Hyperpolarization of arterial smooth muscle induced by endothelial humoral substances. Am J Physiol. 1991;260:H1888-H1892.
52. Garland CJ, McPherson GA. Evidence that nitric oxide does not mediate the hyperpolarization and relaxation to acetylcholine in the rat small mesenteric artery. Br J Pharmacol. 1992;105:429-435.
53. Van de Voorde J, Vanheel B, Leusen I. Endothelium-dependent relaxation and hyperpolarization in aorta from control and renal hypertensive rats. Circ Res. 1992;70:1-8.
54. Silberstein SD, Lipton RB. Overview of diagnosis and treatment of migraine. Neurology. 1996;44(10, suppl 7):S6-S16.
55. Lincoln J. Innervation of cerebral arteries by nerves containing 5-hydroxytryptamine and noradrenaline. Pharmacol Ther. 1996;68:473-501.
56. Jensen R, Hindberg I. Plasma serotonin increase during episodes of tension-type headache. Cephalgia. 1994;14:219-222.
57. Goadsby PJ, Adner M, Edvinsson L. Characterization of endothelin receptors in the cerebral vasculature and their lack of effect on spreading depression. J Cereb Blood Flow Metab. 1996;16:698-704.
58. Brandli P, Loffler BM, Breu V, Osterwalder R, Maire JP, Clozel M. Role of endothelin in mediating neurogenic plasma extravasation in rat dura mater. Pain. 1996;64:315-322.